Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Folic Acid Awareness Campaign Supported By $20 Mil. Proposed In House Bill

This article was originally published in The Tan Sheet

Executive Summary

A national folic acid education program to prevent birth defects would receive $20 mil. in FY 2000 funding and annual sums "as may be necessary" in fiscal 2001 through 2004 under a bill introduced in the House July 15.

You may also be interested in...



Folic Acid, Birth Defects Research Addressed In Children's Health Bill

The "Children's Health Act of 2000" passed the House May 9 by a 419-2 vote under suspension of the rules. The bill (HR 4365) was introduced May 3 by Reps. Michael Bilirakis (R-Fla.) and Sherrod Brown (D-Ohio).

Folic Acid, Birth Defects Research Addressed In Children's Health Bill

The "Children's Health Act of 2000" passed the House May 9 by a 419-2 vote under suspension of the rules. The bill (HR 4365) was introduced May 3 by Reps. Michael Bilirakis (R-Fla.) and Sherrod Brown (D-Ohio).

Folic Acid, Birth Defects Research Addressed In Children's Health Bill

The "Children's Health Act of 2000" passed the House May 9 by a 419-2 vote under suspension of the rules. The bill (HR 4365) was introduced May 3 by Reps. Michael Bilirakis (R-Fla.) and Sherrod Brown (D-Ohio).

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel